European E-Clinical Trials Markets

Published by: Frost & Sullivan

Published: Apr. 8, 2008 - 70 Pages

Table of Contents

1. Executive Summary

1. Summary of European E-Clinical Trial Market

1. Executive Summary of European E-Clinical Trial Market

2. Research Scope and Methodology

1. Research Methodology

1. Research Definition and Scope

3. Glossary

1. Abbreviations

1. Glossary of Terms

4. Introduction and Background

1. Market Overview

1. Market Introduction

5. Market Dynamics

1. Market Trends

1. Industry Challenges

2. Market Drivers

3. Market Restraints

6. Market Engineering Measurements

1. Total Market Engineering Measurements

1. European Market Engineering Measurements

7. Total Revenue Forecast

1. Revenue Forecast

1. European Revenue Forecast

8. Geographical Trends

1. Trends by Geographic Region

1. Trends

9. Strategic Recommendations

1. Strategic Recommendations

1. Market Engineering Strategy

10. Key Industry Participants

1. Key Industry Participants

1. E-Clinical Technology Vendors

11. Decision Support Databases

1. Decision Support Database

1. Decision Support Database

Abstract

This Frost & Sullivan research service titled European E-Clinical Trials Markets provides an overview of market dynamics and key programmes in the market, along with a complete analysis of key market drivers, restraints and trends in the e-clinical technologies markets in Europe. In this research, Frost & Sullivan's expert analyst thoroughly examines the market for Germany, France, the United Kingdom, Italy, Spain, Scandinavia and Benelux.

Cost and Clinical Benefits to Underline Appeal of E-clinical Trials

The pharmaceutical industry and contract research organisations (CROs) have steadily been moving towards greater automation and synergy. This has opened exciting growth potential for e-clinical technologies vendors. The fast-evolving clinical trial industry, in conjunction with information technology providers, has created different levels of opportunities, which, in turn, have influenced the type of clinical trial solutions being offered.

Pressures to increase drug research productivity and the need for enhanced data quality and cost reduction are fuelling the demand for e-clinical solutions. E-clinical technology is addressing the urgent need of bringing about greater efficiency in the drug discovery process and generating significant improvements in productivity. Such benefits are spurring the acceptance of e-clinical technologies. At the same time, e-clinical technologies are enabling life sciences companies to efficiently filter drug candidates by analysing data in real time. This is helping reduce the time required for validation checks, translating to considerable savings and higher revenues through the early introduction of drugs to the market. "Tremendous scope and opportunity exists for e-clinical technology vendors to provide trial solutions and services that support the life sciences industry in being more cost effective and productive," notes Frost & Sullivan Research Analyst E.Sujith. "E-clinical trial solution vendors who can provide a one-shop stop for various types of clinical trial activities are poised to make particularly strong gains."

Changing Regulations and Concerns about ROI to Hamper Adoption of E-clinical Technology

Constantly changing regulations present a serious challenge to sustained market expansion. In addition, there is a pressing need to achieve improved ROI in the coming years. "E-clinical trial solutions offer a promising route to systematically overhaul the functioning of pharmaceutical companies and CROs," remarks the analyst. "However, the level of integration and investment required to realise this goal is high and remains a difficult proposition, and there is a need to convince customers about the ROI of e-clinical technologies, which presents a major challenge in the climate of industry-wide cost cutting."

E-clinical technology vendors should help the clinical trial and pharmaceutical industries in addressing major areas of concern by establishing efficient IT infrastructure, automating paper-based processes and making the systems compliant with regulatory norms. Problems of integration, cost-cutting and intensifying competition in the pharmaceutical industry have prompted the need for innovative e-clinical technologies. With the regulatory authorities tightening the pressure on pharmaceutical companies and CROs, the need for better technology-driven workflows, processes and services has assumed more significance. This has created tremendous opportunities for firms that can provide scalable and cost-effective e-clinical trial solutions.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.